Basic Research on the Microstructure of Rat Bones in the High-Altitude Environment of Qinghai-Tibet Plateau
Abstract
Objective To establish a hypobaric hypoxia rat model in a real high-altitude environment, to investigate the effects of the real high-altitude environment on rat bone mass and bone microstructure using multiple methods such as Micro CT, blood biochemistry, and pathology, and to explore the potential mechanisms involved.
Methods Sprague Dawley (SD) rats were transported to the Yushu Plateau Laboratory (at 4250 m above sea level) in Qinghai Province and kept there for 4, or 8, or 18 months. These groups were designated as H-4, H-8, and H-18, respectively. Upon completion of the high-altitude exposure, these animals were transported to the Molecular Imaging Laboratory, West China Hospital, Sichuan University (at 500 m above sea level) in Chengdu for relevant testing and comparison with the control animals raised in a low-altitude environment for the same durations (designated L-4, L-8, and L-18). The tests performed included blood biochemistry, Micro CT imaging, and pathological assessments such as ELISA, Western blot, and HE and TRAP staining.
Results Compared with that of the control group, the body mass of rats in the H-4 and H-18 groups decreased significantly (H-4 group vs. L-4 group: [513.75±35.10] g vs. [649.18±60.03] g, P<0.01; H-18 group vs. L-18 group: [535.58±66.65] g vs. [670.86±44.96] g, P<0.01). The serum Ca2+ concentration was higher in the H-8 group and H-18 group compared to that in the control group (H-8 group vs. L-8 group: [2.48±0.09] mmol/L vs. [2.38±0.07] mmol/L, P<0.05; H-18 group vs. L-18 group: [2.55±0.11] mmol/L vs. [2.13±0.27] mmol/L, P<0.05). No statistically significant difference was observed in the concentration of P3+. Bone metabolism indicator cross-linked carboxy-terminal telopeptide of type Ⅰ collagen (CTX-Ⅰ) was significantly increased in all high-altitude groups compared to the low-altitude groups (H-4 group vs. L-4 group: [1.44±0.08] ng/mL vs. [0.70±0.13] ng/mL, P<0.01; H-8 group vs. L-8 group: [1.52±0.10] ng/mL vs. [0.75±0.10] ng/mL, P<0.01; H-18 group vs. L-18 group: [2.70±0.13] ng/mL vs. [1.94±0.15] ng/mL, P<0.01). In addition, CT results showed a decrease in bone volume fraction of trabecular bone in the three high-altitude groups (H-4 group vs. L-4 group: [7.48±2.35]% vs. [10.40±2.93]%, P<0.05; H-8 group vs. L-8 group: [7.17±2.68]% vs. [10.09±2.95]%, P<0.05; H-18 group vs. L-18 group: [2.90±2.91]% vs. [8.68±4.11]%, P<0.01), and increased trabecular separation in the three high-altitude groups (H-4 group vs. L-4 group: [0.70±0.12] mm vs. [0.60±0.06] mm, P<0.05; H-8 group vs. L-8 group: [0.68±0.07] mm vs. [0.59±0.05] mm, P<0.01; H-18 group vs. L-18 group: [0.80±0.09] mm vs. [0.70±0.09] mm, P<0.05). TRAP staining showed an increase in osteoclasts in the H-4 and H-18 groups. Western blot results indicated an increase in the expression of receptor activator of nuclear factor-κB ligand (RANKL) and hypoxia inducible factor-1α (HIF-1α) in high-altitude environment, while the expression of osteoprotegerin (OPG) was inhibited.
Conclusion The impact of high-altitude environment on rat femurs is characterized primarily by a reduction in trabecular bone mass and damage to bone microstructure.
Keywords: Hypobaric hypoxia, Bone microstructure, Micro CT, Bone metabolism
Full Text:
PDFReferences
BASNYAT B, MURDOCH D R. High-altitude illness. Lancet, 2003, 361(9373): 1967-1974. doi: 10.1016/S0140-6736(03)13591-X.
CHEN H, CHEN C, QIN Y, et al. Protective effects of epigallocatechin-3-gallate counteracting the chronic hypobaric hypoxia-induced myocardial injury in plain-grown rats at high altitude. Cell Stress Chaperones, 2023, 28(6): 921-933. doi: 10.1007/s12192-023-01386-1.
FANG X, JI Y, LI S, et al. Paeoniflorin attenuates cuproptosis and ameliorates left ventricular remodeling after AMI in hypobaric hypoxia environments. J Nat Med, 2024, 78(3): 664-676. doi: 10.1007/s11418-024-01781-7.
CHEN C, LI B, CHEN H, et al. Epigallocatechin-3-gallate ameliorated iron accumulation and apoptosis and promoted neuronal regeneration and memory/cognitive functions in the hippocampus induced by exposure to a chronic high-altitude hypoxia environment. Neurochem Res, 2022, 47(8): 2254-2262. doi: 10.1007/s11064-022-03611-2.
BRENT M B. A review of the skeletal effects of exposure to high altitude and potential mechanisms for hypobaric hypoxia-induced bone loss. Bone, 2022, 154: 116258. doi: 10.1016/j.bone.2021.116258.
TERRIZZI A R, RUGOLO G, BOZZINI C, et al. Mandibular biomechanical behavior of rats submitted to chronic intermittent or continuous hypoxia and periodontitis. Sleep Breath, 2021, 25(1): 519-527. doi: 10.1007/s11325-020-02158-2.
KOHLER M, LEIBER F, WILLEMS H, et al. Influence of altitude on vitamin D and bone metabolism of lactating sheep and goats1. J Anim Sci, 2013, 91(11): 5259-5268. doi: 10.2527/jas.2013-6702.
USATEGUI-MARTÍN R, DEL REAL Á, SAINZ-AJA J A, et al. Analysis of bone histomorphometry in rat and guinea pig animal models subject to hypoxia. Int J Mol Sci, 2022, 23(21): 12742. doi: 10.3390/ijms232112742.
WANG X M, LIU H, LI J Y, et al. Rosamultin attenuates acute hypobaric hypoxia-induced bone injuries by regulation of sclerostin and its downstream signals. High Alt Med Biol, 2020, 21(3): 273-286. doi: 10. 1089/ham.2019.0113.
LUKS A M, SWENSON E R, BÄRTSCH P. Acute high-altitude sickness. Eur Respir Rev, 2017, 26(143): 160096. doi: 10.1183/16000617.0096-2016.
BRENT M B, EMMANUEL T, SIMONSEN U, et al. Hypobaric hypoxia deteriorates bone mass and strength in mice. Bone, 2022, 154: 116203. doi: 10.1016/j.bone.2021.116203.
BOZZINI C, CHAMPIN G M, ALIPPI R M, et al. Static biomechanics in bone from growing rats exposed chronically to simulated high altitudes. High Alt Med Biol, 2013, 14(4): 367-374. doi: 10.1089/ham.2013.1038.
YAN C, WANG Z, LIU W, et al. Resveratrol ameliorates high altitude hypoxia-induced osteoporosis by suppressing the ROS/HIF signaling pathway. Molecules, 2022, 27(17): 5538. doi: 10.3390/molecules27175538.
ZHANG L, YIN Y, GUO J, et al. Chronic intermittent hypobaric hypoxia ameliorates osteoporosis after spinal cord injury through balancing osteoblast and osteoclast activities in rats. Front Endocrinol (Lausanne), 2023, 14: 1035186. doi: 10.3389/fendo.2023.1035186.
BOZZINI C, PICASSO E O, CHAMPIN G M, et al. Structural and material mechanical quality of femoral shafts in rats exposed to simulated high altitude from infancy to adulthood. High Alt Med Biol, 2016, 17(1): 50-53. doi: 10.1089/ham.2015.0105.
TEISSIER T, TEMKIN V, POLLAK R D, et al. Crosstalk between senescent bone cells and the bone tissue microenvironment influences bone fragility during chronological age and in diabetes. Front Physiol, 2022, 13: 812157. doi: 10.3389/fphys.2022.812157.
APARISI GÓMEZ M P, BAZZOCCHI A. Bone marrow and metabolic bone disease. Semin Musculoskelet Radiol, 2024, 28(5): 515-527. doi: 10. 1055/s-0044-1788692.
XU J, HUANG Z, SHI S, et al. Glial maturation factor-β deficiency prevents oestrogen deficiency-induced bone loss by remodelling the actin network to suppress adipogenesis of bone marrow mesenchymal stem cells. Cell Death Dis, 2024, 15(11): 829. doi: 10.1038/s41419-024-07234-z.
XIE L, CHENG Y, HU B, et al. PCLAF induces bone marrow adipocyte senescence and contributes to skeletal aging. Bone Res, 2024, 12(1): 38. doi: 10.1038/s41413-024-00337-5.
Refbacks
- There are currently no refbacks.



